Curiox BioSystems Co

Curiox BioSystems Co EBITDA Growth YoY

The Year-over-Year EBITDA Growth of Curiox BioSystems Co (445680.KQ) as of Oct 25, 2026 is -29.97 %. In the previous year, Year-over-Year EBITDA Growth was 10.09 % — a change of -396.95% (lower).

EBITDA Growth YoY

-29.97 %

YoY

-396.95%

Last updated:

Year-over-Year EBITDA Growth of Curiox BioSystems Co is 2024 -29.97 % . Year-over-Year EBITDA Growth of Curiox BioSystems Co was 2023 10.09 % . It decreases by -396.95% lower compared to the previous year.

The Curiox BioSystems Co EBITDA Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Growth YoY
Date
EBITDA Growth YoY
Jan 1, 2022
-39.62 KRW
Jan 1, 2023
10.09 KRW
Jan 1, 2024
-29.97 KRW
The Curiox BioSystems Co EBITDA Growth YoY history
YEAREBITDA Growth YoYYoY
-29.97 %-396.95%
10.09 %-125.47%
-39.62 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Curiox BioSystems Co Stock analysis

What does Curiox BioSystems Co do? Curiox BioSystems Co Ltd generates revenue through the manufacture and sale of automation equipment and consumables for cell analysis processes. The company offers cell pretreatment automation devices, washing machines, and plates, alongside high-capacity adapters, strip spacers, and buffer exchanger products. These products are sold to customers in the Life Sciences Tools & Services industry, primarily within the Korean market. The firm's focus on automation solutions for cell analysis drives its product portfolio and customer base. The company's product lines include cell pretreatment automation devices, washing machines, plates, high-capacity adapters, strip spacers, and buffer exchanger products. These items are designed for use in cell analysis processes, targeting clients who require efficient and precise laboratory equipment. The sales of these specialized tools form the core of Curiox BioSystems' revenue streams. Curiox BioSystems operates within the Life Sciences Tools & Services industry, focusing on providing automation solutions for cell analysis. Its products are manufactured and sold directly to end-users in the life sciences sector, including research institutions and laboratories. The company's revenue is derived from the direct sale of its equipment and consumables without intermediaries. Curiox BioSystems Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Curiox BioSystems Co stock

Year-over-Year EBITDA Growth of Curiox BioSystems Co is -29.97 % in 2024.

On Eulerpool you can find the complete historical development of Year-over-Year EBITDA Growth Curiox BioSystems Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA growth measures the percentage change in EBITDA compared to the prior year. It shows changes in operating cash earnings before capital structure effects.

To evaluate Year-over-Year EBITDA Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBITDA Growth.

Year-over-Year EBITDA Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBITDA Growth's Curiox BioSystems Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Growth — Curiox BioSystems Co

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — Curiox BioSystems Co